Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1350039
European Journal of Endocrinology, Vol 135, Issue 1, 39-45
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drexhage, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Drexhage, H.

Autoimmunity and thyroid growth. Where do we stand?

HA Drexhage

This issue of European Journal of Endocrinology contains two articles which have in common the study in humans of the involvement of TSH receptor antibodies (TSH-R-ab) and T cells in goitrous conditions such as Graves' disease and sporadic goitre.

Aust et al. (1) describe activated, i.e. HLA-DR+, T cells not only in Graves goitres but also—and in the same proportions–in goitrous conditions such as non-toxic multinodular goitre (NTG) and thyroid autonomy (TA). Forty per cent of these activated T cells show an intracellular staining for IFN-{gamma}, whereas half of them co-express another activation marker, i.e. CD69. Both NTG and TA are generally regarded as conditions in which the immune system is not activated ("nonautoimmune"), and hence the presence of activated T cells—although clearly in lower numbers as compared to Graves goitres—was surprising to the authors. Because the activation marker CD69 has also been implicated in tolerance induction in the thymus,




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. A. Drexhage
Are There More than Antibodies to the Thyroid-Stimulating Hormone Receptor that Meet the Eye in Graves' Disease?
Endocrinology, January 1, 2006; 147(1): 9 - 12.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. G. Gianoukakis, H. J. Cao, T. A. Jennings, and T. J. Smith
Prostaglandin endoperoxide H synthase expression in human thyroid epithelial cells
Am J Physiol Cell Physiol, March 1, 2001; 280(3): C701 - C708.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies
Endocr. Rev., December 1, 1998; 19(6): 673 - 716.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. P. A. Smyth, S. G. Shering, M. T. Kilbane, M. J. Murray, E. W. M. McDermott, D. F. Smith, and N. J. O’Higgins
Serum Thyroid Peroxidase Autoantibodies, Thyroid Volume, and Outcome in Breast Carcinoma
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2711 - 2716.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
P. J. Simons, F. G. A. Delemarre, and H. A. Drexhage
Antigen-Presenting Dendritic Cells as Regulators of the Growth of Thyrocytes: A Role of Interleukin-1{beta} and Interleukin-6
Endocrinology, July 1, 1998; 139(7): 3148 - 3156.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.